Home » Topics » Neurology/psychiatric, BioWorld Science

Neurology/psychiatric, BioWorld Science
RSS

5-HT2 ligands claimed by Janssen

July 5, 1996

Anxiolytic/antidepressant 5-HT1A receptor ligands from AHP

July 5, 1996

Lilly's 5-HT1F agonists for migraine

July 5, 1996

CRF earns positive results in phase I/II

June 28, 1996

Cypros is granted U.S. patent for CPC-211 dosing regimen

June 28, 1996

Lifarizine shows positive results in efficacy/safety study

June 28, 1996

Suntory describes metabotropic glutamate antagonists

June 28, 1996

RPR reports glutamate antagonists

June 28, 1996

NMDA antagonists synthesized by Hoechst Marion Roussel

June 28, 1996

Takeda seeks German approval for idebenone

June 28, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...